Home » Health » Title: New Berry Shows Promise in Treating Diabetes

Title: New Berry Shows Promise in Treating Diabetes

by Dr. Michael Lee – Health Editor

Novel Fruit Extract Shows Promise in lowering Blood Glucose,‌ Improving Type 2 Diabetes Markers in Mice

Qaidam Basin, China – A fruit​ extract ⁤from ‌ Nitraria roborowskii ​Kom (NRK),‍ a plant native⁢ to ⁤the Qaidam​ Basin in china,‌ has demonstrated⁢ critically ‍important potential in reducing blood glucose levels and improving key metabolic ⁣markers in diabetic mice, ⁣according to new research published in Food Chemistry. The findings suggest NRK fruit⁢ could be‍ a valuable functional ingredient ⁤in food ⁣products⁢ aimed​ at managing Type⁤ 2 Diabetes (T2DM).

Researchers identified 52 chemical ⁤constituents​ within NRK, including 10 β-carboline alkaloids, nine cyclic peptides, ⁢three indole alkaloids,‍ five pyrrole alkaloids, eight⁤ phenolic acids, and ⁤17​ flavonoids. Notably, one new β-carboline alkaloid⁣ and five new cyclic peptides were confirmed through detailed mass spectrometry analysis.

the study revealed that‌ a specific NRK⁣ extract, termed​ NRK-C, exhibited ‍strong inhibitory ⁢activity against⁣ both maltase (IC50 of 0.202 mg/mL) and sucrase (IC50 of‌ 0.103 mg/mL) in vitro. Subsequent in ​vivo experiments showed that NRK-C ‌(400 mg/kg) substantially decreased postprandial blood ⁢glucose (PBG) in diabetic⁣ mice.⁣ Further inquiry demonstrated NRK-C reduced ​fasting blood⁣ glucose levels and ⁣improved glucose ‌tolerance, hepatic glycogen levels, and lipid profiles (total cholesterol, ⁣triglyceride, low-density lipoprotein, and high-density lipoprotein). the extract also significantly reduced insulin​ resistance.

Mechanistic studies indicated that NRK-C upregulated phosphorylated PI3K and p-GSK3β expression, suggesting a modulation⁢ of the PI3K/AKT signaling pathway as a⁢ potential mechanism ​for its antidiabetic effects. Researchers concluded ‍that‌ NRK-C shows promise ‌in improving T2DM ​and could potentially serve as an adjunctive therapy. The‌ study ​utilized a diabetic mouse model created through ⁣a high-fat diet (HFD) combined with six ‍intraperitoneal injections of 35 mg·kg-1 of streptozotocin (STZ). Western blotting and immunofluorescence were used to analyze signaling protein regulation.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.